ALX Oncology Holdings Inc.
ALXO
$0.55
-$0.01-1.79%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 127.76M | 148.57M | 156.72M | 157.44M | 182.74M |
| Total Receivables | 892.00K | 1.20M | 6.24M | 1.10M | 996.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.68M | 6.12M | 5.43M | 9.33M | 4.49M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 27.00K | -- | 315.00K | -- | 439.00K |
| Total Current Assets | 134.35M | 155.90M | 168.71M | 167.86M | 188.66M |
|
|
|||||
| Total Current Assets | 134.35M | 155.90M | 168.71M | 167.86M | 188.66M |
| Net Property, Plant & Equipment | 9.63M | 10.31M | 10.70M | 10.25M | 10.84M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 267.00K | 5.47M | 5.73M | 7.49M | 7.64M |
| Total Assets | 147.78M | 185.72M | 214.62M | 212.65M | 242.55M |
|
|
|||||
| Total Accounts Payable | 4.50M | 7.89M | 8.15M | 6.23M | 8.59M |
| Total Accrued Expenses | 9.26M | 14.85M | 15.16M | 14.29M | 15.44M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.35M | 1.87M | 1.74M | 1.79M | -- |
| Total Finance Division Other Current Liabilities | 2.39M | 7.73M | 13.40M | 9.92M | 11.97M |
| Total Other Current Liabilities | 2.39M | 7.73M | 13.40M | 9.92M | 11.97M |
| Total Current Liabilities | 18.50M | 32.34M | 38.45M | 32.23M | 36.00M |
|
|
|||||
| Total Current Liabilities | 18.50M | 32.34M | 38.45M | 32.23M | 36.00M |
| Long-Term Debt | 9.47M | 9.84M | 9.77M | 9.70M | 9.64M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 5.16M | 5.66M | 5.96M | 5.35M | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.03M | 1.08M | 1.12M | 1.17M | 7.20M |
| Total Liabilities | 34.16M | 48.91M | 55.30M | 48.46M | 52.84M |
|
|
|||||
| Common Stock & APIC | 734.47M | 728.20M | 720.64M | 686.02M | 675.73M |
| Retained Earnings | -621.12M | -591.96M | -561.25M | -521.85M | -486.27M |
| Treasury Stock & Other | 275.00K | 563.00K | -73.00K | 28.00K | 256.00K |
| Total Common Equity | 113.62M | 136.81M | 159.32M | 164.20M | 189.71M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 113.62M | 136.81M | 159.32M | 164.20M | 189.71M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 113.62M | 136.81M | 159.32M | 164.20M | 189.71M |
|
|
|||||